Lineage Cell Therapeutics Inc LCTX

Healthcare Biotechnology

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.

NYSEAM:LCTX - Post by User

Lineage Cell Therapeutics Inc

Bullboard Posts

Post by Outofworkbumon Mar 26, 2013 9:53pm

232 Views

Post# 21172069

Pump and Dump

It has been a long time since I got taken by a P&D scam. Why no chatter? Why only press releases. No income to speak of and yet push push push. I only wish I did my research right BEFOREHAND. I bought at $4.75 and finally bailed at $3.89 because I was goofing off on a beach in Bohol and not watching. Had I been I would have shorted this dead fish....BE WARNED!!!!

Bullboard Posts

NervGen: Are amazing human trial results leaking out?